H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.8% of adults in Des Moines have diagnosed diabetes — about even with the U.S. 12% figure. Census population 214,133. Iowa Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Des Moines clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Des Moines storefront.
Growth Factor Therapy for Tissue Repair in Des Moines, IA for clinics & physicians. Growth factor therapy… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Des Moines is 39.4% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 11.8% of adults in Des Moines have diagnosed diabetes — about even with the U.S. 12% figure. Iowa is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for growth factor therapy, not a walk-in clinic.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Des Moines we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 11.8% of adults in Des Moines have diagnosed diabetes — about even with the U.S. 12% figure.
We are not going to invent a Des Moines warehouse or a five-star local review. What you get is growth factor therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS J5, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 11.8% of adults — about even with the U.S. 12% figure. Obesity is 39.4%; arthritis is 25.6%. That is place-level BRFSS modeling, not a clinic census and not a Des Moines trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Iowa.
No. They are B2B distribution pages for licensed providers. Patients in Des Moines should speak with their clinician, not use a distributor URL as care instructions.
Hawk Medical works with independent reps who already have physician call points. Territory conversations start at /become-a-rep — not by scraping this city URL.
Ask for the IFU, the lot-traceability packet, and the WPS Government Health Administrators article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Des Moines fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Des Moines, IA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Des Moines is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Des Moines — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
Iowa Part B wound biologics follow this contractor (siblings: KS, MO, NE). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Des Moines. Useful for joint-program math; still needs a diagnosis and privileging.
No Des Moines storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.